171 related articles for article (PubMed ID: 28553042)
1. Successful Renal Transplantation Across HLA Barrier: Report from India.
Aggarwal G; Tiwari AK; Dorwal P; Chauhan R; Arora D; Dara RC; Kher V
Indian J Nephrol; 2017; 27(3):210-214. PubMed ID: 28553042
[TBL] [Abstract][Full Text] [Related]
2. Renal transplantation in HLA sensitized patients: Traversing the immunological barrier.
Pandey P; Setya D; Sinha V; Bhatt A; Devra A; Pande A; Kumar P; Ranjan S
Ther Apher Dial; 2020 Oct; 24(5):578-590. PubMed ID: 31863544
[TBL] [Abstract][Full Text] [Related]
3. Flow Cytometric Panel-Reactive Antibody Results and the Ability to Find Transfusion-Compatible Platelets after Antibody-Desensitization for Allogeneic Bone Marrow Transplant.
Rosenbaum ER; Pandey S; Harville TO; Drobena GA; Cottler-Fox M
Ann Clin Lab Sci; 2016 Dec; 46(6):662-665. PubMed ID: 27993881
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of complement-dependent lymphocytotoxicity crossmatch and flow cytometry crossmatch results versus Luminex single-antigen bead-based donor-specific IgG class I antibody MFI values in live related renal transplant cases; a retrospective observation in 102 cases.
Pandey P; Pande A; Kumar Devra A; Kumar Sinha V; Prasad Bhatt A
J Immunoassay Immunochem; 2021 May; 42(3):300-313. PubMed ID: 33356865
[TBL] [Abstract][Full Text] [Related]
5. Significance of Luminex-based single antigen class II bead assay and its mean fluorescence intensity in renal transplant cases; a retrospective observation in 97 cases.
Pande A; Pandey P; Kumar Devra A; Kumar Sinha V; Prasad Bhatt A
J Immunoassay Immunochem; 2020 May; 41(3):322-336. PubMed ID: 32122239
[TBL] [Abstract][Full Text] [Related]
6. Virtual crossmatch in kidney transplantation.
Piazza A; Ozzella G; Poggi E; Caputo D; Manfreda A; Adorno D
Transplant Proc; 2014 Sep; 46(7):2195-8. PubMed ID: 25242749
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Donor-Specific Anti-Human Leukocyte Antigen (HLA) Antibody Rebound on the Risk of Antibody Mediated Rejection in Sensitized Kidney Transplant Recipients.
Lee KW; Park JB; Cho CW; Lee N; Yoo H; Kim K; Park H; Kang ES; Huh W; Kim S
Ann Transplant; 2017 Mar; 22():166-176. PubMed ID: 28348361
[TBL] [Abstract][Full Text] [Related]
8. Epitope Analysis Aids in Transplant Decision Making by Determining the Clinical Relevance of Apparent Pre-Transplant Donor Specific Antibodies (DSA).
Pandey S; Harville TO
Ann Clin Lab Sci; 2019 Jan; 49(1):50-56. PubMed ID: 30814077
[TBL] [Abstract][Full Text] [Related]
9. Frequent development of subclinical chronic antibody-mediated rejection within 1 year after renal transplantation with pre-transplant positive donor-specific antibodies and negative CDC crossmatches.
Yamanaga S; Watarai Y; Yamamoto T; Tsujita M; Hiramitsu T; Nanmoku K; Goto N; Takeda A; Morozumi K; Katayama A; Saji H; Uchida K; Kobayashi T
Hum Immunol; 2013 Sep; 74(9):1111-8. PubMed ID: 23792054
[TBL] [Abstract][Full Text] [Related]
10. Correlation of Luminex-Based Single Antigen Based Results With Complement-Dependent Cytotoxicity Crossmatch and Flow Cytometry Crossmatch Results: A Single-Center Experience From Istanbul.
Oguz SR; Sinangil A; Barlas S; Ciftci HS; Ulusoy E; İzgi DK; Ogret Y; Ecder T; Akin B
Transplant Proc; 2023 Mar; 55(2):303-308. PubMed ID: 36890054
[TBL] [Abstract][Full Text] [Related]
11. HLA Desensitization Based on Results of the Luminex Technique in Kidney Transplant - A Single-center Experience.
Bansal SB; Gade A; Sinha S; Mahapatra A; Jha P; Sethi SK
Indian J Nephrol; 2021; 31(5):454-459. PubMed ID: 34880555
[TBL] [Abstract][Full Text] [Related]
12. Effects of different sensitization events on HLA alloimmunization in renal transplant cases; a retrospective observation in 1066 cases.
Pandey P; Pande A; Mandal S; Devra AK; Sinha VK; Bhatt AP; Mishra S
Transpl Immunol; 2022 Dec; 75():101680. PubMed ID: 35908630
[TBL] [Abstract][Full Text] [Related]
13. Successful kidney transplantation across a positive complement-dependent cytotoxicity crossmatch by using C1q assay-directed, bortezomib-assisted desensitization: A case report.
Lee J; Park BG; Jeong HS; Park YH; Kim S; Kim BS; Kim HJ; Huh KH; Jeong HJ; Kim YS
Medicine (Baltimore); 2017 Sep; 96(39):e8145. PubMed ID: 28953652
[TBL] [Abstract][Full Text] [Related]
14. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
15. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.
Tait BD; Süsal C; Gebel HM; Nickerson PW; Zachary AA; Claas FH; Reed EF; Bray RA; Campbell P; Chapman JR; Coates PT; Colvin RB; Cozzi E; Doxiadis II; Fuggle SV; Gill J; Glotz D; Lachmann N; Mohanakumar T; Suciu-Foca N; Sumitran-Holgersson S; Tanabe K; Taylor CJ; Tyan DB; Webster A; Zeevi A; Opelz G
Transplantation; 2013 Jan; 95(1):19-47. PubMed ID: 23238534
[TBL] [Abstract][Full Text] [Related]
16. Blood levels of donor-specific human leukocyte antigen antibodies after renal transplantation: resolution of rejection in the presence of circulating donor-specific antibody.
Higgins R; Hathaway M; Lowe D; Lam F; Kashi H; Tan LC; Imray C; Fletcher S; Zehnder D; Chen K; Krishnan N; Hamer R; Briggs D
Transplantation; 2007 Oct; 84(7):876-84. PubMed ID: 17984841
[TBL] [Abstract][Full Text] [Related]
17. Combining Sensitive Crossmatch Assays With Donor/Recipient Human Leukocyte Antigen Eplet Matching Predicts Living-Donor Kidney Transplant Outcome.
Meneghini M; Melilli E; Martorell J; Revuelta I; Rigol-Monzó E; Manonelles A; Montero N; Cucchiari D; Diekmann F; Cruzado JM; Gil-Vernet S; Grinyó JM; Bestard O
Kidney Int Rep; 2018 Jul; 3(4):926-938. PubMed ID: 29989033
[TBL] [Abstract][Full Text] [Related]
18. Human leukocyte antigen antibody-incompatible renal transplantation: excellent medium-term outcomes with negative cytotoxic crossmatch.
Higgins R; Lowe D; Hathaway M; Williams C; Lam FT; Kashi H; Tan LC; Imray C; Fletcher S; Chen K; Krishnan N; Hamer R; Daga S; Edey M; Zehnder D; Briggs D
Transplantation; 2011 Oct; 92(8):900-6. PubMed ID: 21968524
[TBL] [Abstract][Full Text] [Related]
19. Outcome of desensitization in human leukocyte antigen- and ABO-incompatible living donor kidney transplantation: a single-center experience in more than 100 patients.
Al Meshari K; Pall A; Chaballout A; El Gamal H; Al Mana H; Humaidan H; Alzayer F; Al Talhi M
Transplant Proc; 2013 May; 45(4):1423-6. PubMed ID: 23726587
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of the baseline donor-specific anti-human leukocyte antigen antibody measured by Luminex single antigen assay in living donor kidney transplant recipients after desensitization therapy.
Chung BH; Choi BS; Oh EJ; Park CW; Kim JI; Moon IS; Kim YS; Yang CW
Transpl Int; 2014 Jan; 27(1):49-59. PubMed ID: 24118413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
